Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

NCT ID: NCT02507856

Last Updated: 2022-05-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10044 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-31

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The multi-center, prospective PRODAST study is investigating patients with non-valvular atrial fibrillation (AF) who experienced an ischemic stroke or a transient ischemic attack (TIA) recently (≤ 1 week) both with and without previous oral anticoagulation. It consists of a baseline visit and a 3 months central follow-up for patients who were discharged with dabigatran, vitamin K-antagonists, antiplatelets only, or no oral antithrombotic treatment at all. Thus, data on the use of dabigatran and vitamin K-antagonists in routine clinical practice will be collected to describe how dabigatran is prescribed and used in the population of AF patients with recent cerebrovascular events and how these factors influence important outcome and safety events. The utilization of dabigatran will be assessed with regards to treatment persistence, compliance, proportion of patients discontinuing treatment and reason for discontinuation as well clinical endpoints such as major bleeding, stroke or systemic embolism. Due to the fact that patients will be treated according to local medical practice it is possible that medication will be changed during the observation period. In the follow-up, data from the first as well as from the second prescribed medication will be used in the study. To explore a long-term effect of anticoagulation, survival up to one year will be assessed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Ischemia With Non-valvular Atrial Fibrillation Transient Ischemic Attack With Non-valvular Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

investigational group

early/late dabigatran

No interventions assigned to this group

control group

vitamin k antagonist (vka)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years at enrollment
* Male or female patient willing and able to provide written informed consent for data transmission. For patients who are not legally competent to sign this informed consent for data transmission exceptions/special cases are described in the protocol.
* Patient with ischemic stroke or TIA within the last 7 days.
* Patient diagnosed with non-valvular AF. Documentation of AF by 12 lead ECG, ECG rhythm strip, monitor print-out, pacemaker/ICD electrocardiogram, Holter ECG (duration of AF episode at least 30 seconds) or written physician´s diagnosis prior to index event needed for all enrolled patients.

Exclusion Criteria

* Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention (surgical or non-surgical) during the next 3 months.
* Current participation in any randomized clinical trial of an experimental drug or device.
* Women of childbearing age without anamnestic exclusion of pregnancy or not using an effective contraception or nursing mothers.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Essen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Hans Diener

Prof. Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hans Diener, Prof. Dr.

Role: STUDY_DIRECTOR

University Hospital, Essen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Altenburger Land GmbH

Altenburg, , Germany

Site Status

Kreisklinik Altötting

Altötting, , Germany

Site Status

Schön Klinik Bad Aibling

Bad Aibling, , Germany

Site Status

Hochtaunus-Kliniken gGmbH, Krankenhaus Bad Homburg

Bad Homburg, , Germany

Site Status

Neurologische Klinik Bad Neustadt a. d. Saale

Bad Neustadt an der Saale, , Germany

Site Status

Klinikum Bayreuth

Bayreuth, , Germany

Site Status

Vivantes Auguste-Viktoria Klinikum

Berlin, , Germany

Site Status

Vivantes Klinikum Neukölln

Berlin, , Germany

Site Status

Unfallkrankenhaus Berlin

Berlin, , Germany

Site Status

Vivantes Humboldt Klinikum GmbH

Berlin, , Germany

Site Status

Evangelisches Krankenhaus Bielefeld gGmbH

Bielefeld, , Germany

Site Status

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH

Bochum, , Germany

Site Status

St. Josef Hospital Ruhr University Bochum

Bochum, , Germany

Site Status

Universitätsklinikum Bonn

Bonn, , Germany

Site Status

Knappschaftskrankenhaus Bottrop GmbH

Bottrop, , Germany

Site Status

Klinikum Bremerhaven-Reinkenheide gGmbH

Bremerhaven, , Germany

Site Status

Krankenhaus Buchholz und Winsen gGmbH

Buchholz, , Germany

Site Status

Evangelisches Krankenhaus Castrop-Rauxel

Castrop-Rauxel, , Germany

Site Status

Allgemeines Krankenhaus Celle

Celle, , Germany

Site Status

REGIOMED-Kliniken - Klinikum Coburg

Coburg, , Germany

Site Status

Universitätsklinikum Köln

Cologne, , Germany

Site Status

Krankenhaus St. Elisabeth gGmbH

Damme, , Germany

Site Status

Klinikum Dortmund gGmbH

Dortmund, , Germany

Site Status

Städtisches Klinikum Dresden-Neustadt

Dresden, , Germany

Site Status

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, , Germany

Site Status

Evangelisches Klinikum Niederrhein gGmbH

Duisburg, , Germany

Site Status

Klinikum Emden, Hans-Susemihl Krankenhaus

Emden, , Germany

Site Status

Alfried Krupp Krankenhaus Rüttenscheid

Essen, , Germany

Site Status

University Hospital Essen, Department of Neurology

Essen, , Germany

Site Status

Klinikum Frankfurt Höchst GmbH

Frankfurt, , Germany

Site Status

Klinikum der Johann Wolfgang Goethe-Universität

Frankfurt am Main, , Germany

Site Status

Universitätsklinikum Freiburg

Freiburg im Breisgau, , Germany

Site Status

Klinikum Fulda gAG

Fulda, , Germany

Site Status

Evangelische Kliniken Gelsenkirchen gGmbH

Gelsenkirchen, , Germany

Site Status

SRH Wald-Klinikum Gera GmbH

Gera, , Germany

Site Status

Universitätsmedizin Göttingen, Georg-August-Universität

Göttingen, , Germany

Site Status

Klinikum Oberberg - Kreiskrankenhaus Gummersbach GmbH

Gummersbach, , Germany

Site Status

Krankenhaus Martha-Maria Halle-Dölau

Halle, , Germany

Site Status

UKH Universitätsklinikum Halle (Saale)

Halle, , Germany

Site Status

Universitätsklinikum Hamburg-Eppendorf

Hamburg, , Germany

Site Status

Asklepios Klinik Wandsbek

Hamburg, , Germany

Site Status

Asklepios Klinik Barmbek

Hamburg, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Evangelisches Krankenhaus Hattingen gGmbH

Hattingen, , Germany

Site Status

Krankenhaus Agatharied GmbH

Hausham, , Germany

Site Status

Universitätsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Evangelisches Krankenhaus Herne

Herne, , Germany

Site Status

BDH-Klinik Hessisch-Oldendorf GmbH

Hessisch Oldendorf, , Germany

Site Status

Klinikum Ibbenbüren GmbH

Ibbenbueren, , Germany

Site Status

Klinikum Idar-Oberstein GmbH

Idar-Oberstein, , Germany

Site Status

SHR Klinikum Karlsbad-Langensteinbach GmbH

Karlsbad, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein, Campus Kiel

Kiel, , Germany

Site Status

Alexianer Krefeld GmbH, Krankenhaus Maria-Hilf

Krefeld, , Germany

Site Status

Universitätsklinikum Leipzig AöR

Leipzig, , Germany

Site Status

Klinikum Main-Spessart, Krankenhaus Lohr

Lohr, , Germany

Site Status

Klinikum der Stadt Ludwigshafen gGmbH

Ludwigshafen, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein Campus Lübeck

Lübeck, , Germany

Site Status

Sana Kliniken Luebeck GmbH

Lübeck, , Germany

Site Status

Städtisches Klinikum Lüneburg gGmbH

Lüneburg, , Germany

Site Status

St.-Marien-Hospital GmbH

Lünen, , Germany

Site Status

Universitätsklinikum Magdeburg

Magdeburg, , Germany

Site Status

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Mainz, , Germany

Site Status

Universitätsmedizin Mannheim

Mannheim, , Germany

Site Status

Klinikum Merzig

Merzig, , Germany

Site Status

Mühlenkreiskliniken AöR, Johannes Wesling Klinikum Minden

Minden, , Germany

Site Status

St. Josef Krankenhaus GmbH Moers

Moers, , Germany

Site Status

Kliniken Maria Hilf GmbH

Mönchengladbach, , Germany

Site Status

UKM Universitätsklinikum Münster

Münster, , Germany

Site Status

Dietrich-Bonhoeffer-Klinikum Neubrandenburg

Neubrandenburg, , Germany

Site Status

Klinikum Osnabrück GmbH

Osnabrück, , Germany

Site Status

Klinikum Vest GmbH, Behandlungszentrum Knappschaftskrankenhaus Recklinghausen

Recklinghausen, , Germany

Site Status

Imland Klinik Rendsburg

Rendsburg, , Germany

Site Status

Klinikum Saarbrücken gGmbH

Saarbrücken, , Germany

Site Status

Nordwest-Krankenhaus Sanderbusch

Sande, , Germany

Site Status

Diakonie-Klinikum Schwäbisch Hall gGmbH

Schwäbisch Hall, , Germany

Site Status

ASKLEPIOS Kliniken Schildautal Seesen

Seesen, , Germany

Site Status

Kreisklinikum Siegen

Siegen, , Germany

Site Status

Medinos Kliniken Sonneberg

Sonneberg, , Germany

Site Status

Klinikum Stuttgart - Katharinenhospital

Stuttgart, , Germany

Site Status

SRH Zentralklinikum Suhl GmbH

Suhl, , Germany

Site Status

Asklepios Fachklinikum Teupitz

Teupitz, , Germany

Site Status

Universitätsklinikum Tübingen

Tübingen, , Germany

Site Status

RKU - Universitäts- und Rehabilitationskliniken Ulm gGmbH

Ulm, , Germany

Site Status

Ammerland Klinik GmbH

Westerstede, , Germany

Site Status

HELIOS Dr. Horst Schmidt Kliniken Wiesbaden

Wiesbaden, , Germany

Site Status

Rems-Murr-Klinikum Winnenden

Winnenden, , Germany

Site Status

Sana HANSE-Klinikum Wismar

Wismar, , Germany

Site Status

Klinikum Wolfsburg

Wolfsburg, , Germany

Site Status

Rhein-Maas-Klinikum GmbH

Würselen, , Germany

Site Status

Universitätsklinikum Würzburg AöR

Würzburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Grosse GM, Husing A, Stang A, Kuklik N, Brinkmann M, Grond M, Rollnik JD, Marquardt L, Kraft A, Schlemm E, Eggers C, Eschenfelder CC, Weimar C, Diener HC. Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke: A Post Hoc Analysis of the PRODAST Study. J Am Heart Assoc. 2025 Feb 4;14(3):e037014. doi: 10.1161/JAHA.124.037014. Epub 2025 Feb 3.

Reference Type DERIVED
PMID: 39895532 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRODAST

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DLBS1033 for Acute Ischemic Stroke Patients
NCT02133521 TERMINATED PHASE2/PHASE3
Beta Blockers In Acute Ischemic Stroke
NCT01061190 COMPLETED PHASE2/PHASE3
Edoxaban for TIA and Acute Minor Stroke
NCT02221102 UNKNOWN PHASE2/PHASE3